Log In
BCIQ
Print this Print this
 

CAD106

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionVaccine containing beta amyloid 1-6 peptide coupled to the virus-like particle Qb
Molecular Target Beta amyloid
Mechanism of ActionDisrupts amyloid plaques; Vaccine
Therapeutic ModalityPreventive vaccine: Peptide vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationAlzheimer's disease (AD)
Indication DetailsPrevent or delay symptoms associated with Alzheimer's disease (AD); Treat mild to moderate Alzheimer's disease (AD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/15/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today